January 2026 in “JAAD International”
May 2023 in “Journal of The American Academy of Dermatology” This correspondence outlines a research aim to evaluate the usefulness of laboratory testing for telogen effluvium to assist in forming evidence-based treatment guidelines, though results are not provided in the abstract.
February 2025 in “Journal of Cosmetic Dermatology” In this study, researchers observed that deficiency in biochemical markers, notably ferritin and serum iron, is frequently found in female patients diagnosed with telogen effluvium, suggesting these tests are crucial in understanding and treating the condition.
15 citations
,
October 2016 in “PubMed” This study found that vitamin D, ferritin, and zinc deficiencies are prevalent among patients with telogen effluvium in the greater Pittsburgh area, suggesting these should be included in initial evaluations.
June 2024 in “Archives of dermatological research” Targeted testing for telogen effluvium patients can save healthcare costs.